All Menu Shortcuts Main Contants Shortcuts

Faculty

Faculty Directory

Dae Yong KIM

Name
Dae Yong KIM, M.D., Ph.D.(adjunct professor)
Faculty Appointment
(title, department)
Professor, Department of Cancer Control and Population Health, NCC-GCSP
Area of Expertise
Radiation Oncology (Gastrointestinal Cancer)
E-mail
radiopia@ncc.re.kr
Work Experience
Specialist, Center for Proton Therapy, National Cancer Center (2003-Present)
Specialist, Department of Radiation Oncology, National Cancer Center (2012-Present)
Director, National Cancer Control Institute, National Cancer Center (2018-Present)
Adjunct, Center for Proton Therapy, National Cancer Center (2019-Present)
Adjunct Scientist, Division of Convergence Technology, Natinoal Cancer Center (2019-Present)
Educational Background
M.D Seoul National University College of Medicine (1981-1988)
M.S Seoul National University College of Medicine (1994-1996)
Ph.D Chungbuk National University College of Medicine (1999-2001)
Research Interests
Proton and radiation therapy for colorectal cancer, treatment method for recurrent colorectal cancer, and predictive factors of chemoradiotherapy before surgery in colorectal cancer.
Achievements (Total: 178 SCI: 120 SCI-E: 54 etc: 4 SSCI: 0 SCI+SCI-E+SSCI: 0)
2019 SCI Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma:SCIENTIFIC REPORTS. 9(1):11770~11770 (4.011)

2019 SCI-E Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer:CANCER RESEARCH AND TREATMENT. Online:Published (3.363)

2019 SCI-E Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?:CANCERS. 11(2):E230~E230 (6.162)

2018 SCI Colorectal cancer susceptibility loci and influence on survival:genes chromosomes cancer. 57(12):630~637 (3.362)

2018 SCI Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis:The British journal of radiology. 91(1092):20180143~20180143 (1.814)

2018 SCI Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy:Journal of Surgical Research. 232:227~233 (2.051)

2018 SCI-E Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer:International journal of clinical oncology. 23(5):924~929 (2.61)

2018 SCI-E Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23:CANCER RESEARCH AND TREATMENT. 50(4):1316~1323 (3.23)

2018 기타 Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boostintensity modulated radiotherapy with and without induction chemotherapy for locally advanced pancreatic cancer:Radiation Oncology Journal. 36(3):200~209 (0)

2018 SCI A Randomized Phase 2 Trial of Consolidation Chemotherapy After Preoperative Chemoradiation Therapy Versus Chemoradiation Therapy Alone for Locally Advanced Rectal Cancer: KCSG CO 14-03:International journal of radiation oncology, biology, physics. 101(4):889~899 (5.554)

2018 SCI-E Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer:Technology in cancer research & treatment. 17:1~9 (1.646)

2018 SCI-E Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings:PLoS One. 13(4):e0195815~e0195815 (2.766)

2017 SCI-E The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma.:Cancer research and treatment. 50(3):1039~1050 (3.772)

2017 SCI-E Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer, a Multicenter Validation Study:Cancer Research and Treatment. 50(2):506~517 (3.772)

2017 SCI-E Clinical Outcomes of Proton Beam Therapy for Choroidal Melanoma at a Single Institute in Korea.:Cancer Research and Treatment. 50(2):335~344 (3.772)

2017 SCI Tolerance design of patient-specific range QA using the DMAIC framework in proton therapy:Medical Physics. 45(2):520~528 (2.617)

2017 SCI Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial:Annals of Surgery. 267(2):243~251 (8.98)

2017 SCI Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance:European Radiology. 28(2):496~505 (3.967)

2017 SCI-E Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma:Oncotarget. 9(3):4034~4043 (5.168)

2017 SCI-E Endoscopic assessment of tumor regression after preoperative chemoradiotherapy as a prognostic marker in locally advanced rectal cancer:Surgical Oncology-Oxford. 26(4):453~459 (3.304)

2017 SCI-E A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis:Radiation Oncology. 12(1):62~62 (2.568)

2016 SCI Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis:Radiotherapy and Oncology. 122(1):122~129 (4.817)

2016 SCI Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases:American Journal of Clinical Oncology. 39(6):623~629 (2.977)

2016 SCI Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection A propensity score-matched analysis and meta-analysis:Medicine. 95(47):e4925~e4925 (2.133)

2016 SCI-E Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis After Resection of Brain Metastases in Breast Cancer Patients:Cancer Research and Treatment. Online:Published (4.245)

2016 SCI-E A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy:Radiation Oncology. 11(1):140~140 (2.466)

2016 SCI Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas:Strahlenther Onkol. 192(9):649~657 (2.898)

2016 SCI Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node?:Surgery. 160(2):366~376 (3.309)

2016 SCI Two-dimensional in vivo rectal dosimetry using an endorectal balloon with unfoldable radiochromic film during prostate cancer radiotherapy:Radiotherapy and oncology. 120(2):327~332 (4.817)

2016 SCI Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer:Radiotherapy and Oncology. 119(3):512~518 (4.817)

2016 SCI Significance of histologic tumor grade in rectal cancer treated with preoperative chemoradiotherapy followed by curative surgery: A multi-institutional retrospective study:Radiotherapy and Oncology. 118:387~392 (4.817)

2015 SCI-E What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients After Preoperative Chemoradiotherapy?:Cancer Research and Treatment. 48(3):998~1009 (3.318)

2015 SCI-E Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer.:Cancer Research and Treatment. 48(2):567~573 (3.318)

2015 SCI Risk factors for permanent stoma after rectal cancer surgery with temporary ileostomy:Surgery. 159(3):721~727 (3.38)

2015 SCI-E Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-term Outcomes:Cancer research and treatment. 48(1):225~231 (3.318)

2015 SCI Development of a novel proton dosimetry system using an array of fiber-optic Cerenkov radiation sensors:Radiotherapy and Oncology. 117(3):501~504 (4.363)

2015 SCI Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma:Strahlentherapie und Onkologie. 191(11):835~844 (2.914)

2015 SCI Normal Liver Sparing by Proton Beam Therapy for Hepatocellular Carcinoma: Comparison with Helical Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy:Acta oncologica. 54(10):1827~1832 (2.997)

2015 SCI Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with wholebrain radiotherapy: a multicenter retrospective study:Journal of Neuro-oncology. 125(2):377~383 (3.07)

2015 SCI Carcinoembryonic antigen has prognostic value for tumor downstaging and recurrence in rectal cancer after preoperative chemoradiotherapy and curative surgery: A multi-institutional and case-matched control study of KROG 14-12.:Radiotherapy and Oncology. 116:202~208 (4.363)

2015 SCI Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer:International Journal of Radiation Oncology Biology Physics. 92:540~547 (4.258)

2015 SCI Can Chemoradiation Allow for Omission of Lateral Pelvic Node Dissection for Locally Advanced Rectal Cancer?:Journal of surgical oncology. 111(4):459~464 (3.244)

2015 SCI-E Robotic Versus Laparoscopic Surgery for Rectal Cancer after Preoperative Chemoradiotherapy: Case-Matched Study of Short-term Outcomes:Cancer research and treatment. 48:225~231 ()

2015 SCI Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis.:The Journal of clinical endocrinology and metabolism. 100(3):1009~1017 (6.209)

2015 SCI The Role of Fibrinogen as a Predictor in Preoperative Chemoradiation for Rectal Cancer:Annals of surgical oncology. 22(1):209~215 (3.93)

2015 SCI-E Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma.:Cancer research and treatment. 47(1):34~45 (3.318)

2014 SCI Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma:Strahlentherapie und Onkologie. 190(10):882~890 (2.733)

2014 SCI Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: Pooled analysis of KROG 10-01 and 11-02:Radiotherapy and oncology. 113(1):18~23 (4.857)

2014 SCI Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.:Strahlentherapie und Onkologie. 190(9):806~814 (2.733)

2014 SCI-E Carbohydrate antigen 19-9 levels associated with pathological responses to preoperative chemoradiotherapy in rectal cancer.:Asian Pacific Journal of Cancer Prevention. 15(13):5383~5387 (1.5)

2014 SCI-E Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients:Journal of digestive diseases. 15(7):367~376 (1.924)

2014 SCI-E Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial:The lancet oncology. 15(7):767~774 (24.725)

2014 SCI-E Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer:Cancer research and treatment : official journal of Korean Cancer Association. 46(2):158~164 (2.975)

2014 SCI Low-mass-ion discriminant equation: A new concept for colorectal cancer screening.:International Journal of Cancer. 134(8):1844~1853 (5.007)

2014 SCI Serpin B5 is a CEA-interacting biomarker for colorectal cancer.:International Journal of Cancer. 134(7):1595~1604 (5.007)

2014 SCI Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy:Annals of surgical oncology. 21(4):1345~1351 (3.943)

2014 SCI-E Expression of phosphoenolpyruvate carboxykinase linked to chemoradiation susceptibility of human colon cancer cells:BMC Cancer. 14:160~160 (3.319)

2014 SCI-E Influence of family history on survival in patients with colon and rectal cancer:Journal of digestive diseases. 15(3):108~115 (1.924)

2014 SCI Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02).:Radiotherapy and Oncology. 110(1):150~154 (4.857)

2013 SCI-E Voxel-based dual time 18F-FDG parametric imaging for rectal cancer: Differentiation of residual tumor from post-chemoradiotherapy changes:Nuclear Medicine Communications. 34(12):1166~1173 (1.379)

2013 SCI-E Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer:Yonsei Medical Journal. 54(6):1362~1369 (1.306)

2013 SCI-E Clinical validity of tissue CEA expression as ancillary to serum CEA concentration in patients curatively resected for colorectal cancer.:Colorectal Disease. 15(9):e503~e511 (2.081)

2013 SCI Preoperative Plasma Hyperfibrinogenemia is Predictive of Poor Prognosis in Patients with Nonmetastatic Colon Cancer:Annals of surgical oncology. 20(9):2908~2913 (4.12)

2013 SCI-E Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy:International Journal of Colorectal Disease. 28(9):1217~1224 (2.238)

2013 SCI-E Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer:Colorectal disease. 15(9):e503~e511 (2.081)

2013 SCI Phase II trial of proton beam accelerated partial breast irradiation in breast cancer:Radiotherapy and Oncology. 108(2):209~214 (4.52)

2013 SCI-E Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer:Radiation Oncology. 8(1):160~160 (2.107)

2013 SCI-E Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy:Radiation Oncology. 8:114~114 (2.107)

2013 SCI Preoperative short-course concurrent chemoradiation therapy followed by delayed surgery for locally advanced rectal cancer: a phase 2 multicenter study (KROG 10-01):International Journal of Radiation Oncology, Biology, Physics. 86(1):34~39 (4.524)

2013 SCI-E Association between CASR polymorphisms, calcium intake, and colorectal cancer risk:PLoS One. 8:e59628~e59628 (3.73)

2013 SCI Laparoscopic versus open surgery in stage I rectal cancer: Long-term oncologic outcomes:World Journal of Surgery. 37(3):646~651 (2.228)

2013 SCI Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy:Tumori. 99(1):93~99 (0.922)

2013 SCI Curative radiotherapy using different radiation techniques for isolated lung metastasis from colorectal cancer:Tumori. 99(1):68~75 (0.922)

2013 SCI Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases:Journal of Korean medical science. 28(2):205~212 (1.249)

2013 SCI-E A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy:Radiation Oncology. 8:28~28 (2.107)

2013 SCI KRAS Mutation Status and Clinical Outcome of Preoperative Chemoradiation With Cetuximab in Locally Advanced Rectal Cancer: A Pooled Analysis of 2 Phase II Trials.:International Journal of Radiation Oncology Biology Physics. 85(1):201~207 (4.524)

2013 SCI-E New Application of Dual Point 18F-FDG PET/CT in the Evaluation of Neoadjuvant Chemoradiation Response of Locally Advanced Rectal Cancer:Clinical nuclear medicine. 38(1):7~12 (2.955)

2012 SCI-E Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009:Cancer Research and Treatment. 44(4):219~226 (0)

2012 SCI-E Up-regulated expression of l-caldesmon associated with malignancy of colorectal cancer:BMC Cancer. 12(1):601~601 (3.011)

2012 SCI Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection.:International journal of radiation oncology, biology, physics.. 84:e585~e592 (4.105)

2012 SCI Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).:Int J Radiat Oncol Biol Phys. 84:955~961 (4.105)

2012 SCI Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?:Cancer. 118:4961~4968 (4.771)

2012 SCI Monte Carlo Modeling and Validation of a Proton Treatment Nozzle by Using the Geant4 Toolkit:Journal of the Korean Physics Society. 61:1125~1130 (0.447)

2012 SCI Feasibility study of glass dosimeter for In Vivo Measurement: Dosimetric characterization and clinical application in proton beams:International Journal of Radiation Oncology, Biology, Physics. 84(2):e251~e256 (4.105)

2012 SCI The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery:Annals of Oncology. 23(10):2731~2737 (6.425)

2012 기타 An Update on Preoperative Radiotherapy for Locally Advanced Rectal Cancer:J Korean Soc Coloproctol. 28:179~187 (0)

2012 SCI-E Lymph Node Ratio is an Independent Prognostic Factor in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy and Curative Resection.:European Journal of Surgical Oncology. 38(6):478~483 (2.499)

2012 SCI Hydroxymethylglutaryl-Coenzyme A Synthase 2 Expression Is Associated With Chemoradiotherapy Responses in Colorectal Cancer:Diseases of the Colon & Rectum. 55(6):686~694 (3.132)

2012 SCI Reply to Letter: 'What Does Residual Nodal Positivity in Patients With Rectal Cancer Downstaged to ypT0 After Chemoradiotherapy Really Mean?'.:Annals of surgery. 255(5):e2~e2 (7.492)

2012 SCI-E Clinical outcomes of palliative self-expanding metallic stents in patients with malignant colorectal obstruction:Journal of Digestive Diseases. 13(5):258~266 (1.589)

2012 SCI No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients:Clinica Chimica Acta. 413(3-4):511~515 (2.535)

2012 SCI Tumor Volume Reduction Rate After Preoperative Chemoradiotherapy as a Prognostic Factor in Locally Advanced Rectal Cancer.:International journal of radiation oncology, biology, physics.. 82(2):e193~e199 (4.105)

2012 SCI Stage-to-stage Comparison of Pre-operative and Post-operative Chemoradiotherapy for T3 Mid or Distal Rectal Cancer:Int. J. Radiation Oncology Biol. Phys.. 82(2):856~862 (4.105)

2011 SCI CA 19-9 Level as Indicator of Early Distant Metastasis and Therapeutic Selection in Resected Pancreatic Cancer:International Journal of Radiation Oncology, Biology, Physics. 81:743~748 (4.503)

2011 SCI Role of Adjuvant Chemoradiotherapy for Resected Extrahepatic Biliary Tract Cancer.:International journal of radiation oncology, biology, physics.. 81:853~859 (4.503)

2011 SCI The Effect of a Contrast Agent on Proton Beam Range in Radiotherapy Planning Using Computed Tomography for Patients With Locoregionally Advanced Lung Cancer.:International journal of radiation oncology, biology, physics.. 81:317~324 (4.503)

2011 SCI Pretreatment Carbohydrate Antigen 19-9 Level Indicates Tumor Response, Early Distant Metastasis, Overall Survival, and Therapeutic Selection in Localized and Unresectable Pancreatic Cancer.:International journal of radiation oncology, biology, physics.. 81:623~630 (4.503)

2011 SCI Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter phase II study:International journal of radiation oncology, biology, physics. 81:677~683 (4.503)

2011 SCI Is step section necessary for determination of complete pathological response in rectal cancer patients treated with preoperative chemoradiotherapy?:Histopathology. 59:650~659 (3.569)

2011 SCI Prognostic Significance of Distribution of Lymph Node Metastasis in Advanced Mid or Low Rectal Cancer:Journal of surgical oncology.. 104(5):486~492 (2.428)

2011 SCI Characteristics and prognosis of patients with colorectal cancer-associated brain metastases in the era of modern systemic chemotherapy:Journal of Neurooncology. 104(3):745~753 (2.929)

2011 SCI Is the N1c category of the new american joint committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?:Cancer. 117(17):3917~3924 (5.131)

2011 SCI-E Clinical Outcomes of Chemoradiotherapy for Locally Recurrent Rectal Cancer.:Radiation Oncology. 6:51~51 (2.409)

2011 SCI-E Prediction of output factor, range, and spread-out Bragg peak for proton therapy.:Medical Dosimetry. 36(2):145~152 (0.941)

2011 SCI Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study:International Journal of Radiation Oncology Biology Phyics. 79(4):1171~1178 (4.503)

2010 SCI The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation.:Journal of surgical oncology. 102:789~795 (2.502)

2010 SCI The role of omental flap transposition in patients with locoregional recurrent rectal cancer treated with reirradiation.:Journal of surgical oncology. 102:789~795 (2.502)

2010 SCI Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01).:Annals of Surgery. 252:998~1004 (7.9)

2010 SCI Curative chemoradiotherapy for isolated retroperitoneal lymph node recurrence of colorectal cancer.:Radiotherapy and oncology. 97:307~311 (4.343)

2010 SCI Absence of hMLH1 or hMSH2 Expression as a Stage-Dependent Prognostic Factor in Sporadic Colorectal Cancers.:ANNALS OF SURGICAL ONCOLOGY. 16(4):356~361 (4.13)

2010 SCI-E Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction:Radiation Oncology. 5:97~97 (2.529)

2010 SCI Tumor Volume Reduction Rate Measured by Magnetic Resonance Volumetry Correlated with Pathologic Tumor Response of Preoperative Chemoradiotherapy for Rectal Cancer.:International Journal of Radiation Oncology Biology Physics. 78(1):164~171 (4.592)

2010 SCI Early Intrapulmonary Recurrence After Pulmonary Metastasectomy Related to Colorectal Cancer:Annals of Thoracic Surgery. 90:398~405 (3.644)

2010 SCI-E Local Excision Following Preoperative Chemoradiotherapy-induced Downstaging for Selected cT3 Distal Rectal Cancer.:Japanese Journal of Clinical Oncology. 40:754~760 (1.498)

2010 SCI Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancers.:Annals of Surgery. 252(2):336~340 (7.9)

2010 SCI Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer.:Journal of Surgical Oncology. 102:94~99 (2.502)

2010 SCI-E Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial:Lancet oncology. 11(7):637~645 (14.47)

2009 SCI Pathologic Nodal Classification Is the Most Discriminating Prognostic Factor for Disease-Free Survival in Rectal Cancer Patients Treated with Preoperative Chemoradiotherapy and Curative Resection:international journal of radiation oncology biology physics. 77(4):1158~1165 (4.592)

2009 SCI Prognostic impact of peritonealisation in rectal cancer treated with preoperative chemoradiotherapy: Extraperitoneal versus intraperitoneal rectal cancer.:Radiotherapy and Oncology. 94(3):353~358 (4.343)

2009 SCI Resected Colorectal Liver Metastases:Does the Survival Differ According to Postoperative Chemotherapy Regimen?:Journal of Surgical Oncology. 100:713~718 (2.478)

2009 SCI-E Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer:International Journal of Colorectal Disease. 24:1451~1458 (1.767)

2009 SCI Microscopic Gold Particle-based Fiducial Makers for Proton Therapy of Prostate Cancer:International Journal of Radiation Oncology Biology Physics. 74(5):1609~1616 (4.639)

2009 SCI-E Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer.:BMC Cancer. Online:Published (3.087)

2009 SCI Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery:International Journal of Radiation Oncology Biology Physics. 74:810~817 (4.639)

2009 SCI-E Radiation pneumonitis after adjuvant radiotherapy for breast cancer: a volumetric analysis using CT simulator:Journal of Breast Cancer. 12(2):73~78 (0)

2009 SCI Secondary Neutron Doses for Several Beam Configurations for Proton Therapy:International Journal of Radiation Oncology Biology Physics. 74(1):260~265 (4.639)

2008 SCI A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer:Investigational New Drugs. Online:Published (2.806)

2008 SCI Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma:International Journal of Radiation Oncology Biology Physics. 72:687~694 (4.29)

2008 SCI Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers:Annals of Surgery. 248:243~251 (7.446)

2008 SCI Computerized tomography-based quality assurance tool for proton range compensators:Medical Physics. 35:3511~3517 (3.198)

2008 기타 Proton Beam Therapy:Journal of Korean Medical Association. 51:638~642 ()

2008 SCI Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment:International Journal of Radiation Oncology, Biology, Physics. 71:1091~1102 (4.29)

2008 SCI-E Synchronous penile metastasis from a rectal carcinoma:International Journal of Colorectal Disease. 23:333~334 (1.918)

2008 SCI Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection:Annals of Surgical Oncology. 15:729~737 (3.917)

2008 SCI SMART (Simultaneous Modulated Accelerated RadioTherapy) for locally advanced nasopharyngeal carcinomas.:Head & Neck. 30:159~169 (2.007)

2007 SCI-E Optimal matching of 3D film-measured and planned doses for intensity-modulated radiation therapy quality assurance:Medical Dosimetry. 32:316~324 (0)

2007 SCI Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer:International journal of radiation oncology, biology, physics. 69:1167~1172 (4.463)

2007 SCI Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer.:Diseases of the Colon & Rectum. 50:1342~1353 (2.442)

2007 SCI Histopathologic risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type:Journal of Clinical Pathology. 60:912~915 (2.245)

2007 SCI Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: Preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy:International Journal of Radiation Oncology Biology Physics. 68:1446~1454 (4.463)

2007 SCI-E Optimized matching of film dosimetry with calculated doses for IMRT quality assurance:Physica Medica. 23:49~57 (0.313)

2007 SCI-E A new homogeneity index based on statistical analysis of the dose-volume histogram:Journal of Applied Clinical Medical Physics. 8:9~17 ()

2007 SCI Intensity-modulated radiotherapy with a belly board for rectal cancer:International Journal of Colorectal Disease. 22:373~379 (2.006)

2007 SCI Endoscopic treatment of completely occluding anastomotic web using incision and ballooning after dye injection:Endoscopy. 39:E102~103 (3.605)

2007 SCI Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer:International Journal of Radiation Oncology Biology Physics. 67:378~384 (4.463)

2007 SCI Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy:International Journal of Radiation Oncology Biology Physics. 67:225~231 (4.556)

2006 SCI Three-dimensional conformal radiotherapy for unresectable hepatocellular carcinoma patients who were Ineffective to or unsuitable for transcatheter arterial chemoembolization.:American journal of clinical oncology. 29:568~575 (1.615)

2006 SCI Three-Dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable:American Journal of Clinical Oncology. 29:568~575 (1.615)

2006 SCI-E Analysis of microsatellite instability in stool DNA of patients with colorectal cancer using denaturing high performance liquid chromatography:World Journal of Gastroenterology. 12(41):6689~6692 ()

2006 SCI Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01):Diseases of the Colon & Rectum. 49:1684~1691 (2.264)

2006 SCI Geometric Shifting of Porta Hepatis during posthepatectomy radiotherapy for biliary tract cancer:international journal of radiation oncology biology physics. 66:212~216 (4.556)

2006 SCI The effect of belly board location in rectal cancer patients treated with preoperative radiotherapy:Clinical Oncology. 18:441~446 (1.288)

2006 SCI A new evaluation method of target volume coverage and homogeneity for IMRT treatment planning:Physica Medica. 22:43~51 (0.169)

2006 SCI Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?:Cancer. 106:1694~1700 (4.8)

2006 SCI Preoperative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge.:EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. 32:162~167 (1.882)

2006 SCI CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.:International Journal of Radiation Oncology Biology Physics. 64(1):197~204 (4.556)

2005 SCI Comparative Analysis of the effects of belly board and bladder distension in postoperative radiotherapy of rectal cancer patients:Strahlentherapie und Onkologie. 181(9):601~605 (3.121)

2005 SCI Dose-volumetric Parameters of Acute Esophageal Toxicity in Patients with Lung Cancer Treated with Three Dimensional Radiotherapy:International Journal of Radiation Oncology Biology Physics. 62:995~1002 (4.297)

2005 SCI A Predictive Marker for Therapeutic Response to Preoperative Chemoradiotherapy in Rectal Carcinoma Patients.:HUMAN PATHOLOGY. 36:364~371 ()

2005 SCI Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung cancer:Radiology. 235(1):208~224 (5.076)

2005 SCI Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung cancer:Radiology. 235:208~223 (4.815)

2005 SCI 3-Dimensional Conformal Radiotherapy for Portal Vein Thrombosis of Hepatocellular Carcinoma.:CANCER. 103:2419~2426 (4.434)

2005 SCI Usefulness of MR Volumetric Evaluation in Predicting Response to Preoperative Concurrent Chemoradiotherapy in Patients with Resectable Rectal Cancer.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 62:761~768 ()

2005 SCI Comparison of the belly board device method and the distended bladder method for reducing irradiated small bowel volumes in preoperative radiotherapy of rectal cancer patients:Int J Rad Oncol Biol Phy. 0:1918~1924 (4.285)

2004 SCI Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma:Human Pathology. 36(4):364~371 (3.685)

2004 SCI Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view.:BRITISH JOURNAL OF CANCER. 91:11~17 ()

2004 SCI-E Granular cell tumor of colon: Report of a case and review of literature.:WORLD JOURNAL OF GASTROENTEROLOGY. 10:2452~2454 ()

2004 SCI-E Granular cell tumor of colon: report a case and review of literature:World Journal of Gastroenterology. 10:2452~2454 ()

2003 Other A case of primary leiomyosarcoma of the inferior vena cava treated by surgical resection and reconstruction with synthetic graft replacement:Korean Journal of Gastroenterology. 42:249~254 ()

2003 SCI Postoperative chemoradiotherapy for gastric cancer:ANNALS OF ONCOLOGY. 14:1373~1377 ()

2002 SCI Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.:JOURNAL OF KOREAN MEDICAL SCIENCE. 17:537~543 ()

2001 SCI CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?:ANNALS OF ONCOLOGY. 12:349~352 ()

2001 SCI Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer.:ACTA ONCOLOGICA. 40:588~592 ()

2000 SCI Fractionated Stereotactic Radiation Therapy for Exracranial Head and Neck Tumors.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 48:501~505 ()

2000 SCI Prompt Radiation Oncology Record Access by Patient Centered Digital Image Chart System at Samsung Medical Center.:RADIOTHERAPY AND ONCOLOGY. 56:117~120 ()

2000 SCI An integrated service digital network (ISDN)-based international telecommunication between Samsung Medical Center and Hokkaido University using telecommunication helped radiotherapy planning and information system (THERAPIS).:RADIOTHERAPY AND ONCOLOGY. 56:121~123 ()

2000 SCI Physical Properties of New Collimator Cone System for Stereotactic Radiation Therapy Developed in Samsung Medical Center.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 48:541~544 ()

2000 SCI A Glass Compensator Filter to Improve Breast Image Quality in Radiation Therapy Simulation.:INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 46:1061~1064 ()